Hinton; Paul R.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hinton; Paul R..The latest application filed is for "anti-cd25 antibodies and their uses".
Company Profile
2.22.31
- Hinton; Paul R. - Sunnyvale CA
- Hinton; Paul R. - Fremont CA
- Hinton, Paul R. - Mountain View CA
Patent Activity
| Patent | Date |
|---|---|
| Interleukin-13 binding proteins Grant 11,344,621 - Wu , et al. May 31, 2 | 2022-05-31 |
| Anti-cd25 Antibodies And Their Uses App 20200308290 - AKAMATSU; Yoshiko ; et al. | 2020-10-01 |
| Interleukin-13 Binding Proteins App 20190008966 - Wu; Chengbin ; et al. | 2019-01-10 |
| Fc variants with improved complement activation Grant 10,150,814 - Hinton , et al. Dec | 2018-12-11 |
| Interleukin-13 binding proteins Grant 10,086,076 - Wu , et al. October 2, 2 | 2018-10-02 |
| Fc Variants App 20180251565 - HARDING; Fiona A. ; et al. | 2018-09-06 |
| Interleukin -13 Binding Proteins App 20170340737 - WU; Chengbin ; et al. | 2017-11-30 |
| Anti-cd25 Antibodies And Their Uses App 20170233481 - AKAMATSU; Yoshiko ; et al. | 2017-08-17 |
| Interleukin-13 binding proteins Grant 9,592,293 - Wu , et al. March 14, 2 | 2017-03-14 |
| Fc Variants With Improved Complement Activation App 20160137732 - HINTON; Paul R. ; et al. | 2016-05-19 |
| Anti-cd25 Antibodies And Their Uses App 20150010539 - AKAMATSU; YOSHIKO ; et al. | 2015-01-08 |
| Fc Variants App 20140377253 - HARDING; Fiona A. ; et al. | 2014-12-25 |
| Prostaglandin E2 Binding Proteins And Uses Thereof App 20140186377 - Gu; Jijie ; et al. | 2014-07-03 |
| IL-12/p40 BINDING PROTEINS App 20140178332 - Lacy; Susan E. ; et al. | 2014-06-26 |
| Interleukin-13 Binding Proteins App 20140099313 - WU; Chengbin ; et al. | 2014-04-10 |
| IL-12/p40 binding proteins Grant 8,629,257 - Lacy , et al. January 14, 2 | 2014-01-14 |
| Alteration of Fc-fusion protein serum half-lives by mutagenesis Grant 8,624,007 - Hinton , et al. January 7, 2 | 2014-01-07 |
| Interleukin-13 binding proteins Grant 8,604,177 - Wu , et al. December 10, 2 | 2013-12-10 |
| Alteration Of Fc-fusion Protein Serum Half-lives By Mutagenesis App 20110183412 - Hinton; Paul R. ; et al. | 2011-07-28 |
| Interleukin-13 Binding Proteins App 20110165066 - Wu; Chengbin ; et al. | 2011-07-07 |
| Interleukin-13 binding proteins Grant 7,915,388 - Wu , et al. March 29, 2 | 2011-03-29 |
| Anti-CCR5 antibody Grant 7,851,600 - Olson , et al. December 14, 2 | 2010-12-14 |
| IL-12/p40 BINDING PROTEINS App 20100196315 - LACY; Susan E. ; et al. | 2010-08-05 |
| Alteration of Fc-fusion protein serum half-lives by mutagenesis Grant 7,732,570 - Hinton , et al. June 8, 2 | 2010-06-08 |
| IL-12/p40 binding proteins Grant 7,700,739 - Lacy , et al. April 20, 2 | 2010-04-20 |
| Il-12/p40 Binding Proteins App 20100047245 - Lacy; Susan E. ; et al. | 2010-02-25 |
| Anti-CCR5 antibody Grant 7,666,419 - Olson , et al. February 23, 2 | 2010-02-23 |
| Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof App 20090232801 - Hillen; Heinz ; et al. | 2009-09-17 |
| Humanized Antibodies To Ab (20-42) Globulomer And Uses Thereof App 20090175847 - Barghorn; Stefan ; et al. | 2009-07-09 |
| Alteration of Fc-fusion protein serum half-lives by mutagenesis App 20080287657 - Hinton; Paul R. ; et al. | 2008-11-20 |
| Amphiregulin Antibodies And Their Use To Treat Cancer And Psoriasis App 20080226632 - Landolfi; Nicholas F. ; et al. | 2008-09-18 |
| Interleukin-13 binding proteins App 20080171014 - Wu; Chengbin ; et al. | 2008-07-17 |
| Anti-CCR5 antibody App 20080107595 - Olson; William C. ; et al. | 2008-05-08 |
| Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis Grant 7,361,740 - Hinton , et al. April 22, 2 | 2008-04-22 |
| Amphiregulin antibodies and their use to treat cancer and psoriasis Grant 7,223,393 - Landolfi , et al. May 29, 2 | 2007-05-29 |
| Alteration of Fc-fusion protein serum half-lives by mutagenesis Grant 7,217,798 - Hinton , et al. May 15, 2 | 2007-05-15 |
| Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis Grant 7,217,797 - Hinton , et al. May 15, 2 | 2007-05-15 |
| Anti-CCR5 antibody App 20070031408 - Olson; William C. ; et al. | 2007-02-08 |
| Anti-CCR5 antibody Grant 7,122,185 - Olson , et al. October 17, 2 | 2006-10-17 |
| Antibodies against CTLA4 and uses therefor App 20060165706 - Carreno; Beatriz M. ; et al. | 2006-07-27 |
| Antibodies against CTLA4 Grant 7,034,121 - Carreno , et al. April 25, 2 | 2006-04-25 |
| Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis App 20050276799 - Hinton, Paul R. ; et al. | 2005-12-15 |
| Alteration of Fc-fusion protein serum half-lives by mutagenesis App 20050226864 - Hinton, Paul R. ; et al. | 2005-10-13 |
| Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis App 20050032114 - Hinton, Paul R. ; et al. | 2005-02-10 |
| Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis App 20050014934 - Hinton, Paul R. ; et al. | 2005-01-20 |
| Amphiregulin antibodies and their use to treat cancer and psoriasis App 20040210040 - Landolfi, Nicholas F. ; et al. | 2004-10-21 |
| Anti-CCR5 antibody App 20030228306 - Olson, William C. ; et al. | 2003-12-11 |
| Antibodies against CTLA4 and uses therefor App 20020039581 - Carreno, Beatriz M. ; et al. | 2002-04-04 |
| Antibodies having modified carbohydrate content and methods of preparation and use App 20020028486 - Morrison, Sherie L. ; et al. | 2002-03-07 |
| Antibodies having modified carbohydrate content and methods of preparation and use Grant 6,218,149 - Morrison , et al. April 17, 2 | 2001-04-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 